Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Skyward Specialty SKWD in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 4 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 2 | 1 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Skyward Specialty, presenting an average target of $39.29, a high estimate of $44.00, and a low estimate of $31.00. Observing a 7.64% increase, the current average has risen from the previous average price target of $36.50.
Analyzing Analyst Ratings: A Detailed Breakdown
In examining recent analyst actions, we gain insights into how financial experts perceive Skyward Specialty. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $43.00 | $41.00 |
| Mark Hughes | Truist Securities | Raises | Buy | $44.00 | $40.00 |
| Matthew Carletti | JMP Securities | Raises | Market Outperform | $40.00 | $38.00 |
| Matthew Carletti | JMP Securities | Raises | Market Outperform | $38.00 | $35.00 |
| Bill Carcache | Wolfe Research | Announces | Outperform | $39.00 | - |
| Michael Zaremski | BMO Capital | Raises | Market Perform | $31.00 | $29.00 |
| C. Gregory Peters | Raymond James | Raises | Strong Buy | $40.00 | $36.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Skyward Specialty. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Skyward Specialty compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Skyward Specialty's stock. This comparison reveals trends in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Skyward Specialty's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Skyward Specialty analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Delving into Skyward Specialty's Background
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to a number of market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.
Financial Insights: Skyward Specialty
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Skyward Specialty showcased positive performance, achieving a revenue growth rate of 2.95% as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Skyward Specialty's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 11.88%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Skyward Specialty's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.89% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Skyward Specialty's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.01%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.19.
The Significance of Analyst Ratings Explained
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
